Ignite Creation Date:
2024-05-06 @ 6:56 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05837884
Status:
RECRUITING
Last Update Posted:
2023-12-07
First Post:
2023-04-20
Brief Title:
Predicting Progression of Developing Myeloma in a High-Risk Screened Population
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Tel-Aviv Sourasky Medical Center
Organization Data
Organization:
Tel-Aviv Sourasky Medical Center
Class:
OTHER_GOV
Study ID:
PROMISE-ISRAEL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Dana-Farber Cancer Institute | OTHER |